The company's board approved a quarterly cash dividend of $2.21 per share, maintaining its shareholder return policy. However, it is simultaneously implementing modest employee pay raises of 0-2% and has conducted layoffs. The business faces significant headwinds, including weaker revenue guidance for 2026, rising medical costs, and pressure on Medicare-related margins, which are challenging its profitability. These factors present a mixed operational and financial outlook.